News

March 9, 2020March 9, 2020

Lesser-known DNA Repair Process May Be Therapeutic Target in Certain Breast Cancers, Study Says

News

Some breast cancers with mutations in DNA damage repair genes may rely on a DNA repair enzyme called polymerase theta for survival, a new study shows, suggesting that blocking this enzyme ... Read more

March 6, 2020March 6, 2020

Breast Cancer Cells Precisely Mapped; Study Notes Potential for Individualized Treatment

News

Researchers have mapped, at the single-cell level, the diverse types and arrangements of cells within breast cancer tumors, revealing how genetic changes shape the complex tumor landscape. The findings could ... Read more

March 5, 2020March 5, 2020

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

News

In recognition of Rare Disease Day Feb. 29, BioNews Services launched a social media campaign last month asking patients to describe what makes them rare. Running Feb. 7–29, the #WhatMakesMeRare ... Read more

March 4, 2020March 4, 2020

Novel 3D Model Provides Early Insights on Breast Cancer Spread

News

Mesenchymal stem cells — cells that can give rise to many cell types and travel to tumor sites — can reduce the capacity of breast cancer cells to spread to ... Read more

February 28, 2020March 23, 2020

FDA Approves Nerlynx-Capecitabine Combo for HER2-positive Metastatic Breast Cancer

News

Nerlynx (neratinib) is now approved in the U.S. for use, in combination with capecitabine, to treat HER2-positive breast cancer patients who have received two or more HER2-targeted therapies for their metastatic ... Read more

February 26, 2020February 26, 2020

New Formulation of Roche’s Perjeta-Herceptin Combo for HER2-Positive Breast Cancer Up for Possible FDA Approval

News

The U.S. Food and Drug Administration (FDA) will review Roche’s application seeking regulatory approval for a new formulation — given as a subcutaneous, or under-the-skin injection — of the fixed-dose ... Read more

February 24, 2020March 5, 2020

Magseed Approval Extended in Europe for Soft Tissues, Long-Term Implantation

News

Magseed, a small magnetic marker by Endomag designed to accurately mark the site of cancer cells before surgery, is now approved in Europe for use in any soft tissue and ... Read more

February 21, 2020February 21, 2020

Adding Keytruda to Chemo Slows Worsening in Advanced TNBC with PD-L1 Markers, Trial Finds

News

First-line treatment with Keytruda (pembrolizumab) and chemotherapy prolongs the time without disease worsening in people with advanced triple-negative breast cancer (TNBC) whose tumors are positive for the marker PD-L1, an interim analysis ... Read more

February 19, 2020February 19, 2020

Tucatinib Granted FDA Priority Review for Advanced HER2-positive Breast Cancer

News

The U.S. Food and Drug Administration (FDA) has granted priority review to Seattle Genetics’ application seeking approval of its investigational therapy tucatinib, in combination with trastuzumab and Xeloda (capecitabine), for treating people with locally advanced inoperable or metastatic HER2-positive breast cancer. This ... Read more

February 17, 2020February 17, 2020

Tutu Project’s Pilot Program Helps Breast Cancer Patients Directly With Daily Expenses

News

The Tutu Project has awarded its first direct grants to patients and families battling breast cancer, as part of a new pilot program to help patients with their daily expenses. ... Read more